Please provide your email address to receive an email when new articles are posted on . The CDC, IDSA and other agencies created updated guidance for treating drug-susceptible and drug-resistant TB.

The World Health Organization is expected to recommend truncating treatment of children with mild tuberculosis by 2 months — from 6 months to 4 — after a randomized trial found similar outcomes with ...

Germantown, Maryland, and Venlo, the Netherlands, June 27, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it welcomes new guidelines in the United ...

The Department of Health - Cordillera region urged residents anew to undergo testing for tuberculosis (TB) and avail of the government’s free medication to prevent the spread of the disease. “Wag ...

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing ...

Zimbabwe is set to roll out a Shorter, Highly-effective, Oral Regimen for Rifampicin-resistant Tuberculosis (SHORRT therapy) which reduces the length of treatment for Multi-Drug Resistant Tuberculosis ...

A new all-oral six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculosis (RR-TB) than the current accepted standard of care, according to results announced ...

Work is underway in South Africa to amend the country’s national guidelines for drug-resistant tuberculosis (DR-TB) to provide a shorter, six-month, all-oral regimen as a new standard of care ...

Tuberculosis (TB) may last for several months, with treatment. The length of time it takes to cure the condition can vary. It may depend on whether the TB is latent or active. Tuberculosis (TB) is a ...